is buying Allergan in a deal expected to be completed soon. The changes are effective before the bell on May 12, S&P Dow Jones said.
An Atlas Venture affiliate just paid $10 million for more shares of Magenta Therapeutics. Atlas is also the fourth-largest shareholder in sports-betting company DraftKings.
Claudia Assis is a San Francisco-based reporter for MarketWatch. Follow her on Twitter @ClaudiaAssisMW.
          All quotes are in local exchange time.
          Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
          Intraday data delayed at least 15 minutes or per exchange requirements.
